Dare Bioscience Inc reports results for the quarter ended in June - Earnings Summary

Dare Bioscience

10/08/2023 15:19

* Dare Bioscience Inc  DARE.OQ  reported a quarterly
adjusted loss
of 10 cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 10
cents per share.
    * Reported revenue was zero​; analysts expected $733.33
thousand. 
    * Dare Bioscience Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts had fallen by
about 19.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Dare Bioscience Inc shares had fallen by 19.6% this
quarter and
lost 11.8% so far this year.
    * The company reported a quarterly loss of $8.76 million.
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $5.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:19 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.10          -0.10          Met
 Mar. 31 2023      -0.10          -0.09          Beat
 Dec. 31 2022      -0.14          -0.19          Missed
 Sep. 30 2022      -0.12          -0.08          Beat